Nuvalent to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nuvalent, Inc.(Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creatingpreciselytargeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference onTuesday, January 13, 2026, at9:00 a.m. PTin San Francisco. https://mma.prnewswire.com/media/1583941/Nuvalent_Inc_Logo_2024.jpg A live webcast will be available in the […]

The Future of Pet Care: How Independence Pet Holdings Is Closing the Gap Between Rising Costs and Unconditional Care

With veterinary costs climbing and the human-animal bond stronger than ever, IPH shares 2025 insights and unveils innovations-from employer-based benefits to predictive health tools-to help pet parents focus on care, not cost The bond between people and pets has never been stronger-97% of pet owners say their pet is family, 77% call their pet their

BEN (Nasdaq: BNAI) Reduces Q4 2025 Liabilities by Approximately $2.5 Million Through Debt Conversions

Brand Engagement Network, Inc.(Nasdaq: BNAI) (“BEN” or the “Company”), a developer of secure and governed multimodal artificial intelligence solutions for regulated industries, today announced that it reduced outstanding liabilities by approximately $2.5 million during the fourth quarter of 2025through a series of debt-to-equity conversions, negotiated settlements, and payments. https://mma.prnewswire.com/media/2777074/Brand_Engagement_Network_LOGO.jpg On December 20, 2025, several long-term

HONEYWELL PROVIDES SUPPLEMENTAL FINANCIAL INFORMATION FOR PLANNED SEGMENT REALIGNMENT; ADJUSTS OUTLOOK TO EXCLUDE ADVANCED MATERIALS

Honeywell (NASDAQ: HON) today released supplemental 2024 and year-to-date 2025 financial information to reflect its updated business segment structure expected to become effective for the first quarter of 2026, which it previously announced on October 22, 2025. https://mma.prnewswire.com/media/1420781/Honeywell_Logo.jpg The company also announced today that it will report its Advanced Materials business unit as discontinued operations

The Real Cost of AI? Beyond Originality, It’s Human Identity

How global thought leader Dr. Tae Yun Kim is redefining human agency, expertise, & purpose in the AI era Artificial Intelligence (AI) is no longer a distant or abstract concept. It is embedded in how people work, communicate, learn, and make decisions every day. Research from McKinsey & Co. estimates that up to 30% of

U.S. Luxury Home Market Shows Mixed Pricing and Divergent Selling Speeds

National luxury prices ease while select markets see rapid turnover National luxury home prices continued to soften in November 2025, with the 90th-percentile threshold dipping to $1.20 million, down 2.3% from a year ago, according to the NovemberRealtor.com® Luxury Housing Report. While the ultraluxury segment showed modest monthly growth, the broader luxury market is experiencing

Johnson Van Kwawegen LLP Announces Securities Litigation Leader Chad Johnson as Co-Founding Partner

Chad Johnson to joinJeroen van Kwawegen to accelerate the firm's rise as a premier global investor-rights litigation firmThree partners to depart Robbins Geller Rudman & Dowd LLP alongside Chad Johnson Van Kwawegen LLP (also known as “JVK Law” or “JVK”) today announced that Chad Johnson, widely recognized as one of the nation's leading securities litigators,

The9 Limited Announces Result of Annual General Meeting

The9 Limited(the “Company”) (Nasdaq:NCTY), an established Internet company, today announced that the following proposed resolution submitted for shareholder approval have been duly adopted at its annual general meeting (the “AGM”) of shareholders held in Hong Kong today: — as an ordinary resolution, that Mr.Zhu Jun, whose term of office shall expire on the date of

Thyme Care to Present at the 44th Annual J.P. Morgan Healthcare Conference

— Helping to support more than 90,000 actively treated cancer patients and responsible for over $5B in oncology spend, Thyme Care has the scale and integrated infrastructure to influence cost, quality, and experience across specialty care — AI and technology backbone create visibility across the cancer journey, enabling earlier intervention, better patient experience, reduced volatility,

Scroll to Top